OM
insider transactionsOutset Medical, Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 365d
-66.2K
0 buy · 66.2K sell
Net value · 365d
-$308.7K
$0 in · $308.7K out
Sentiment · 365d
Net selling
0% buying · 100% selling
Open-market trades · 365d
16
0 buy · 66.2K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Grant·A
Director
$0
10.7K sh
Own +57%
-
Grant·A
Director
$0
10.7K sh
Own +44%
-
Grant·A
Director
$0
10.7K sh
Own +60%
-
Grant·A
Director
$0
10.7K sh
Own +11%
-
Grant·A
Director
$0
10.7K sh
Own +77%
-
Grant·A
Director
$0
10.7K sh
Own +100%
-
Sell·S
Renee Gaeta KEY
Chief Financial Officer
$87.3K
17.7K sh · $4.94
Own -13%
-
Grant·A
Director
$0
1.6K sh
Own +77%
-
Exercise·X
10% Owner
$1.6M
323.0K sh · $5.00
Own +15%
-
Sell·S
Leslie Trigg KEY
Chair and CEO
$12.7K
3.4K sh · $3.70
Own -3%
-
Sell·S
EVP Operations R&D & Service
$5.9K
1.6K sh · $3.70
Own -4%
-
Sell·S
General Counsel
$9.8K
2.6K sh · $3.70
Own -8%
-
Exercise·X
10% Owner
$484.5K
96.9K sh · $5.00
Own +5%
-
Exercise·X
10% Owner
$988.0K
197.6K sh · $5.00
Own +10%
-
Grant·A
Director
$0
34.2K sh
Own New
-
Grant·A
EVP, Commercial
$0
96.0K sh
Own New
-
Grant·A
Director
$0
13.9K sh
Own New
-
Sell·S
Leslie Trigg KEY
Chair and CEO
$11.3K
3.4K sh · $3.35
Own -3%
-
Sell·S
EVP Operations R&D & Service
$6.1K
1.8K sh · $3.35
Own -4%
-
Sell·S
General Counsel
$9.5K
2.8K sh · $3.35
Own -8%
-
Sell·S
Leslie Trigg KEY
Chair and CEO
$10.7K
2.1K sh · $5.05
Own -2%
-
Sell·S
EVP Operations R&D & Service
$4.9K
980 sh · $4.98
Own -2%
-
Sell·S
General Counsel
$5.9K
1.2K sh · $5.01
Own -3%
-
Sell·S
Leslie Trigg KEY
Chair and CEO
$60.4K
11.8K sh · $5.12
Own -10%
-
Sell·S
EVP Operations R&D & Service
$27.5K
5.4K sh · $5.12
Own -11%
-
Sell·S
General Counsel
$47.7K
9.3K sh · $5.12
Own -20%
-
Grant·A
Director
$0
18.7K sh
Own New
-
Sell·S
Leslie Trigg KEY
Chair and CEO
$7.7K
1.8K sh · $4.27
Own -1%
-
Sell·S
EVP Operations R&D & Service
$461
108 sh · $4.27
Own -0%
-
Sell·S
General Counsel
$956
224 sh · $4.27
Own -0%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 4, 2026 | Karen Prange | Grant A | 10.7K | $0 |
| Jun 4, 2026 | Kevin C Oboyle | Grant A | 10.7K | $0 |
| Jun 4, 2026 | Brent D. Lang | Grant A | 10.7K | $0 |
| Jun 4, 2026 | Patrick T Hackett | Grant A | 10.7K | $0 |
| Jun 4, 2026 | Keith D Grossman | Grant A | 10.7K | $0 |
| Jun 4, 2026 | Karen Drexler | Grant A | 10.7K | $0 |
| Jun 3, 2026 | Renee Gaeta KEY | Sell S | 17.7K | $87.3K |
| May 27, 2026 | Kevin C Oboyle | Grant A | 1.6K | $0 |
| May 15, 2026 | Braden Michael Leonard | Exercise X | 323.0K | $1.6M |
| May 15, 2026 | Leslie Trigg KEY | Sell S | 3.4K | $12.7K |
| May 15, 2026 | Marc Nash | Sell S | 1.6K | $5.9K |
| May 15, 2026 | John L. Brottem | Sell S | 2.6K | $9.8K |
| May 11, 2026 | Braden Michael Leonard | Exercise X | 96.9K | $484.5K |
| May 8, 2026 | Braden Michael Leonard | Exercise X | 197.6K | $988.0K |
| May 6, 2026 | Karen Drexler | Grant A | 34.2K | $0 |
| Apr 6, 2026 | Derick A. Elliott | Grant A | 96.0K | $0 |
| Mar 9, 2026 | Keith D Grossman | Grant A | 13.9K | $0 |
| Feb 17, 2026 | Leslie Trigg KEY | Sell S | 3.4K | $11.3K |
| Feb 17, 2026 | Marc Nash | Sell S | 1.8K | $6.1K |
| Feb 17, 2026 | John L. Brottem | Sell S | 2.8K | $9.5K |
| Jan 21, 2026 | Leslie Trigg KEY | Sell S | 2.1K | $10.7K |
| Jan 21, 2026 | Marc Nash | Sell S | 980 | $4.9K |
| Jan 21, 2026 | John L. Brottem | Sell S | 1.2K | $5.9K |
| Jan 20, 2026 | Leslie Trigg KEY | Sell S | 11.8K | $60.4K |
| Jan 20, 2026 | Marc Nash | Sell S | 5.4K | $27.5K |
| Jan 20, 2026 | John L. Brottem | Sell S | 9.3K | $47.7K |
| Jan 9, 2026 | Karen Prange | Grant A | 18.7K | $0 |
| Jan 7, 2026 | Leslie Trigg KEY | Sell S | 1.8K | $7.7K |
| Jan 7, 2026 | Marc Nash | Sell S | 108 | $461 |
| Jan 7, 2026 | John L. Brottem | Sell S | 224 | $956 |
About OM insider trading
This page tracks insider transactions for Outset Medical, Inc. (OM) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.